Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management
- 11 September 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 151 (1), 1-17
- https://doi.org/10.1093/ajcp/aqy087
Abstract
Objectives Point-of-care (POC) testing is generally less precise and has higher reagent costs per test than laboratory-based assays. However, POC hemostasis testing can offer significant advantages in particular situations: patient-managed warfarin therapy as well as rapid turnaround time heparin management for intraoperative patients. Of note, POC hemostasis testing is generally approved for the purposes of anticoagulation monitoring and is inferior to laboratory coagulation testing for the diagnosis of congenital or acquired coagulopathy. Methods The frequently used POC coagulation instruments for POC international normalized ratio and activated clotting time are reviewed, as well as their typical performance relative to central laboratory testing (where available). Results Several cases are discussed that highlight the benefits, as well as pitfalls, of POC coagulation testing. Conclusions POC coagulation testing for anticoagulation monitoring offers advantages in particular situations. Clear policies and protocols must be developed to guide proper use of POC versus central laboratory hemostasis testing.Keywords
This publication has 94 references indexed in Scilit:
- Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years’ experienceJournal of Clinical Pathology, 2012
- Evidence-Based Management of Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Functional definition and characterization of acute traumatic coagulopathyCritical Care Medicine, 2011
- Heparin Concentration–Based Anticoagulation for Cardiac Surgery Fails to Reliably Predict Heparin Bolus Dose RequirementsAnesthesia & Analgesia, 2010
- Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral AnticoagulantsStroke, 2009
- A Comparison of Activated Coagulation Time–Based Techniques for Anticoagulation During Cardiac Surgery With Cardiopulmonary BypassJournal of Cardiothoracic and Vascular Anesthesia, 2008
- An evidence‐based review and guidelines for patient self‐testing and management of oral anticoagulationBritish Journal of Haematology, 2005
- Validation of the i-STAT handheld activated clotting time for use with bivalirudinThe American Journal of Cardiology, 2004
- Evaluation of a New Point-of-care Celite-activated Clotting Time Analyzer in Different Clinical SettingsAnesthesiology, 2003
- Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary interventionAmerican Heart Journal, 1999